Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Melançon P[au]:

Search results

Items: 1 to 50 of 70

1.

BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.

Chan CJ, Le R, Burns K, Ahmed K, Coyaud E, Laurent EMN, Raught B, Melançon P.

Mol Cell Proteomics. 2019 Nov;18(11):2285-2297. doi: 10.1074/mcp.RA119.001645. Epub 2019 Sep 13.

PMID:
31519766
2.

The Arf-GDP-regulated recruitment of GBF1 to Golgi membranes requires domains HDS1 and HDS2 and a Golgi-localized protein receptor.

Quilty D, Chan CJ, Yurkiw K, Bain A, Babolmorad G, Melançon P.

J Cell Sci. 2018 Apr 19;132(4). pii: jcs208199. doi: 10.1242/jcs.208199.

3.

Scyl1 scaffolds class II Arfs to specific subcomplexes of coatomer through the γ-COP appendage domain.

Hamlin JN, Schroeder LK, Fotouhi M, Dokainish H, Ioannou MS, Girard M, Summerfeldt N, Melançon P, McPherson PS.

J Cell Sci. 2014 Apr 1;127(Pt 7):1454-63. doi: 10.1242/jcs.136481. Epub 2014 Jan 30.

4.

Arf activation at the Golgi is modulated by feed-forward stimulation of the exchange factor GBF1.

Quilty D, Gray F, Summerfeldt N, Cassel D, Melançon P.

J Cell Sci. 2014 Jan 15;127(Pt 2):354-64. doi: 10.1242/jcs.130591. Epub 2013 Nov 8.

5.

Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development.

Elwell CA, Jiang S, Kim JH, Lee A, Wittmann T, Hanada K, Melancon P, Engel JN.

PLoS Pathog. 2011 Sep;7(9):e1002198. doi: 10.1371/journal.ppat.1002198. Epub 2011 Sep 1. Erratum in: PLoS Pathog. 2013 Aug;9(8). doi: 10.1371/annotation/f8e7c7e3-c347-4243-9146-db77900cb90c.

6.

Y-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle production.

Chatel-Chaix L, Melançon P, Racine MÈ, Baril M, Lamarre D.

J Virol. 2011 Nov;85(21):11022-37. doi: 10.1128/JVI.00719-11. Epub 2011 Aug 17.

7.

Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patients.

Jouan L, Chatel-Chaix L, Melançon P, Rodrigue-Gervais IG, Raymond VA, Selliah S, Bilodeau M, Grandvaux N, Lamarre D.

J Hepatol. 2012 Jan;56(1):70-7. doi: 10.1016/j.jhep.2011.07.017. Epub 2011 Aug 9.

PMID:
21835140
8.

Evolution and diversity of the Golgi.

Klute MJ, Melançon P, Dacks JB.

Cold Spring Harb Perspect Biol. 2011 Aug 1;3(8):a007849. doi: 10.1101/cshperspect.a007849.

9.

Arf3 is activated uniquely at the trans-Golgi network by brefeldin A-inhibited guanine nucleotide exchange factors.

Manolea F, Chun J, Chen DW, Clarke I, Summerfeldt N, Dacks JB, Melançon P.

Mol Biol Cell. 2010 Jun 1;21(11):1836-49. doi: 10.1091/mbc.E10-01-0016. Epub 2010 Mar 31.

10.

Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease.

Jouan L, Melançon P, Rodrigue-Gervais IG, Raymond VA, Selliah S, Boucher G, Bilodeau M, Grandvaux N, Lamarre D.

J Hepatol. 2010 Feb;52(2):167-75. doi: 10.1016/j.jhep.2009.11.011. Epub 2009 Nov 27.

PMID:
20006398
11.

ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells.

Boulay PL, Cotton M, Melançon P, Claing A.

J Biol Chem. 2008 Dec 26;283(52):36425-34. doi: 10.1074/jbc.M803603200. Epub 2008 Nov 6.

12.

Characterization of class I and II ADP-ribosylation factors (Arfs) in live cells: GDP-bound class II Arfs associate with the ER-Golgi intermediate compartment independently of GBF1.

Chun J, Shapovalova Z, Dejgaard SY, Presley JF, Melançon P.

Mol Biol Cell. 2008 Aug;19(8):3488-500. doi: 10.1091/mbc.E08-04-0373. Epub 2008 Jun 4.

14.

GBF1, a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi protein traffic.

Zhao X, Claude A, Chun J, Shields DJ, Presley JF, Melançon P.

J Cell Sci. 2006 Sep 15;119(Pt 18):3743-53. Epub 2006 Aug 22.

15.

The Arf6 GEF GEP100/BRAG2 regulates cell adhesion by controlling endocytosis of beta1 integrins.

Dunphy JL, Moravec R, Ly K, Lasell TK, Melancon P, Casanova JE.

Curr Biol. 2006 Feb 7;16(3):315-20.

16.

Reticulon 3 is involved in membrane trafficking between the endoplasmic reticulum and Golgi.

Wakana Y, Koyama S, Nakajima K, Hatsuzawa K, Nagahama M, Tani K, Hauri HP, Melançon P, Tagaya M.

Biochem Biophys Res Commun. 2005 Sep 9;334(4):1198-205.

PMID:
16054885
17.

On the action of Brefeldin A on Sec7-stimulated membrane-recruitment and GDP/GTP exchange of Arf proteins.

Cherfils J, Melançon P.

Biochem Soc Trans. 2005 Aug;33(Pt 4):635-8.

PMID:
16042561
18.

The domain architecture of large guanine nucleotide exchange factors for the small GTP-binding protein Arf.

Mouratou B, Biou V, Joubert A, Cohen J, Shields DJ, Geldner N, Jürgens G, Melançon P, Cherfils J.

BMC Genomics. 2005 Feb 17;6:20.

19.

Exo1: a new chemical inhibitor of the exocytic pathway.

Feng Y, Yu S, Lasell TK, Jadhav AP, Macia E, Chardin P, Melancon P, Roth M, Mitchison T, Kirchhausen T.

Proc Natl Acad Sci U S A. 2003 May 27;100(11):6469-74. Epub 2003 May 8.

20.
22.

Inhibition of CMP-sialic acid transport into Golgi vesicles by nucleoside monophosphates.

Chiaramonte M, Koviach JL, Moore C, Iyer VV, Wagner CR, Halcomb RL, Miller W, Melançon P, Kuchta RD.

Biochemistry. 2001 Nov 27;40(47):14260-7.

PMID:
11714280
24.
25.

Studies on the inhibition of endosome fusion by GTPgammaS-bound ARF.

Jones AT, Spiro DJ, Kirchhausen T, Melançon P, Wessling-Resnick M.

J Cell Sci. 1999 Oct;112 ( Pt 20):3477-85.

26.

GBF1: A novel Golgi-associated BFA-resistant guanine nucleotide exchange factor that displays specificity for ADP-ribosylation factor 5.

Claude A, Zhao BP, Kuziemsky CE, Dahan S, Berger SJ, Yan JP, Armold AD, Sullivan EM, Melançon P.

J Cell Biol. 1999 Jul 12;146(1):71-84.

27.

p200 ARF-GEP1: a Golgi-localized guanine nucleotide exchange protein whose Sec7 domain is targeted by the drug brefeldin A.

Mansour SJ, Skaug J, Zhao XH, Giordano J, Scherer SW, Melançon P.

Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7968-73.

28.

Fusogenic domains of golgi membranes are sequestered into specialized regions of the stack that can be released by mechanical fragmentation.

Dominguez M, Fazel A, Dahan S, Lovell J, Hermo L, Claude A, Melançon P, Bergeron JJ.

J Cell Biol. 1999 May 17;145(4):673-88.

29.

Human GBF1 is a ubiquitously expressed gene of the sec7 domain family mapping to 10q24.

Mansour SJ, Herbrick JA, Scherer SW, Melançon P.

Genomics. 1998 Dec 1;54(2):323-7.

PMID:
9828135
30.
31.

Inhibition of UDP-N-acetylglucosamine import into Golgi membranes by nucleoside monophosphates.

Traynor AJ, Hall ET, Walker G, Miller WH, Melançon P, Kuchta RD.

J Med Chem. 1996 Jul 19;39(15):2894-9.

PMID:
8709123
32.

Human ARF4 expression rescues sec7 mutant yeast cells.

Deitz SB, Wu C, Silve S, Howell KE, Melançon P, Kahn RA, Franzusoff A.

Mol Cell Biol. 1996 Jul;16(7):3275-84.

33.

Purification and mass spectrometric analysis of ADP-ribosylation factor proteins from Xenopus egg cytosol.

Boman AL, Taylor TC, Berger SJ, Melançon P, Wilson KL.

Biochemistry. 1996 Jun 25;35(25):8244-51.

PMID:
8679579
35.

3'-Azidothymidine (zidovudine) inhibits glycosylation and dramatically alters glycosphingolipid synthesis in whole cells at clinically relevant concentrations.

Yan JP, Ilsley DD, Frohlick C, Steet R, Hall ET, Kuchta RD, Melançon P.

J Biol Chem. 1995 Sep 29;270(39):22836-41.

36.
37.
38.

3'-Azido-3'-deoxythymidine potently inhibits protein glycosylation. A novel mechanism for AZT cytotoxicity.

Hall ET, Yan JP, Melançon P, Kuchta RD.

J Biol Chem. 1994 May 20;269(20):14355-8.

39.
40.

Vesicle traffic: G whizz.

Melançon P.

Curr Biol. 1993 Apr 1;3(4):230-3. No abstract available.

PMID:
15335774
41.

The 5' proximal helix of 16S rRNA is involved in the binding of streptomycin to the ribosome.

Pinard R, Payant C, Melançon P, Brakier-Gingras L.

FASEB J. 1993 Jan;7(1):173-6.

PMID:
7678560
42.

Targeting and fusion in vesicular transport.

Sztul ES, Melançon P, Howell KE.

Trends Cell Biol. 1992 Dec;2(12):381-6.

PMID:
14731960
43.
44.

A role for ADP-ribosylation factor in nuclear vesicle dynamics.

Boman AL, Taylor TC, Melançon P, Wilson KL.

Nature. 1992 Aug 6;358(6386):512-4.

PMID:
1641041
45.
46.

Vesicle budding: insights from cell-free assays.

Melançon P, Franzusoff A, Howell KE.

Trends Cell Biol. 1991 Dec;1(6):165-71.

PMID:
14731860
47.

The interaction between streptomycin and ribosomal RNA.

Leclerc D, Melançon P, Brakier-Gingras L.

Biochimie. 1991 Dec;73(12):1431-8.

PMID:
1725256
48.

Mutations in the 915 region of Escherichia coli 16S ribosomal RNA reduce the binding of streptomycin to the ribosome.

Leclerc D, Melançon P, Brakier-Gingras L.

Nucleic Acids Res. 1991 Jul 25;19(14):3973-7.

49.

A deletion mutation at the 5' end of Escherichia coli 16S ribosomal RNA.

Melançon P, Leclerc D, Brakier-Gingras L.

Biochim Biophys Acta. 1990 Aug 27;1050(1-3):98-103.

PMID:
2207175
50.

The anti-Shine-Dalgarno region in Escherichia coli 16S ribosomal RNA is not essential for the correct selection of translational starts.

Melançon P, Leclerc D, Destroismaisons N, Brakier-Gingras L.

Biochemistry. 1990 Apr 3;29(13):3402-7.

PMID:
2185838

Supplemental Content

Loading ...
Support Center